High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma

Interleukin-enhancer binding factor 3 (ILF3) is a double-stranded RNA-binding protein that has been reported to contribute to the occurrence and progression of various malignant tumors. The aim of the present study was to evaluate the prognostic value of ILF3 and to apply this knowledge to avoid exc...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhangyan, Huang, Hua, Li, Xing, Ji, Cheng, Liu, Yifei, Liu, Xiaojuan, Zhu, Jun, Wang, Zhendong, Zhang, Haijian, Shi, Jiahai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039148/
https://www.ncbi.nlm.nih.gov/pubmed/32194712
http://dx.doi.org/10.3892/ol.2020.11330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7039148/
https://www.ncbi.nlm.nih.gov/pubmed/32194712
http://dx.doi.org/10.3892/ol.2020.11330

Ejemplares similares